AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

Tango Therapeutics, Inc.

$22.72 +$13.79 (+154.42%)
NASDAQ · 30 Oct 2026 20:00 UTC
Previous Close
$22.53
Day Range
$21.71$22.75
Year Range
$7.37$34.39
Market Cap
3.83B
AVG Volume
3.3M
Trailing/Forward PE
-26.73/-
PEG ratio
-0.42
Dividend Yield
-
Next Earnings Date
2026-11-03
Primary Exchange
NASDAQUS
Revenue (USD) · TTM
020M40M60M80M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
TNGX Revenue (USD) by quarter, trailing twelve months
PeriodRevenue (USD)
26 Q253.81M
26 Q156.99M
25 Q462.38M
25 Q366.5M
25 Q224.3M
25 Q140.99M
24 Q442.07M
24 Q343.38M
24 Q242.51M
24 Q137.23M
Net Income (USD) · TTM
-150M-100M-50M024 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
TNGX Net Income (USD) by quarter, trailing twelve months
PeriodNet Income (USD)
26 Q2-123.72M
26 Q1-107.23M
25 Q4-101.59M
25 Q3-100.52M
25 Q2-145.57M
25 Q1-132.26M
24 Q4-130.3M
24 Q3-123.39M
24 Q2-116.49M
24 Q1-111.65M
Operating Income (USD) · TTM
-200M-150M-100M-50M024 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
TNGX Operating Income (USD) by quarter, trailing twelve months
PeriodOperating Income (USD)
26 Q2-136.35M
26 Q1-117.53M
25 Q4-111.29M
25 Q3-110.33M
25 Q2-157.28M
25 Q1-145.87M
24 Q4-145.59M
24 Q3-139.7M
24 Q2-132.45M
24 Q1-126.14M
EBITDA · TTM
Cash Flows · TTM
EPS · TTM
Expenses · TTM
Cash & Debt · TTM
Debt ratios · TTM
Margins · TTM
Return on Capital · TTM
Shares Outstanding · TTM
Dividends (USD) · TTM
Employee Count
Book Value Per Share · TTM
Total Assets · TTM
PE Ratio
Free Cash Flow Yield
Price to Sales
EV/EBITDA
Price/Operating Cashflow
Price to Book

Earnings: TNGX

Estimate against actual revenue and earnings per share, the beat and miss record of recent reports, and how the price moved around each one. Next report: 3 Nov 2026.

Tango Therapeutics, Inc.
TNGX
Stockpicker

Video analysis: TNGX

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

News: TNGX

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.